OQS
PASG icon

Occudo Quantitative Strategies’s Passage Bio PASG Stock Holding History

Occudo Quantitative Strategies’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,388
Closed -$26.6K – 1211
2023
Q1 		$26.6K Hold
1,388
– – ﹤0.01% 864
2022
Q4 		$38.3K Hold
1,388
– – ﹤0.01% 898
2022
Q3 		$35K Sell
1,388
-1,453
-51% -$57.3K ﹤0.01% 1112
2022
Q2 		$134K Buy
2,841
+626
+28% +$29.2K 0.01% 976
2022
Q1 		$137K Buy
+2,215
New +$183K 0.01% 995

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Occudo Quantitative Strategies's PASG Position: Q2 2023 in Review

Occudo Quantitative Strategies sold out of Passage Bio (PASG) in Q2 2023, closing a stake of 1,388 shares — an estimated $26.6K sold.

Occudo Quantitative Strategies first reported a position in PASG in Q1 2022 and held it in 5 quarters. The position peaked at $137K in Q1 2022. 54 funds tracked by Wall St. Rank hold PASG as of Q2 2023.

  • Occudo Quantitative Strategies reported no remaining Passage Bio position as of Q2 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 1,388 Passage Bio shares in Q2 2023, an estimated $26.6K.
  • Occudo Quantitative Strategies first reported a position in Passage Bio in Q1 2022 and held it in 5 quarters.
  • Occudo Quantitative Strategies's Passage Bio position peaked at $137K in Q1 2022.
  • 54 funds tracked by Wall St. Rank held Passage Bio as of Q2 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.